Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma

Maartje W Rohaan, Troels H Borch, Joost H van den Berg, Özcan Met, Rob Kessels, Marnix H Geukes Foppen, Joachim Stoltenborg Granhøj, Bastiaan Nuijen, Cynthia Nijenhuis, Inge Jedema, Maaike van Zon, Saskia Scheij, Jos H Beijnen, Marten Hansen, Carlijn Voermans, Inge M Noringriis, Tine J Monberg, Rikke B Holmstroem, Lidwina D V Wever, Marloes van DijkLindsay G Grijpink-Ongering, Ludy H M Valkenet, Alejandro Torres Acosta, Matthias Karger, Jessica S W Borgers, Renske M T Ten Ham, Valesca P Retèl, Wim H van Harten, Ferry Lalezari, Harm van Tinteren, Astrid A M van der Veldt, Geke A P Hospers, Marion A M Stevense-den Boer, Karijn P M Suijkerbuijk, Maureen J B Aarts, Djura Piersma, Alfons J M van den Eertwegh, Jan-Willem B de Groot, Gerard Vreugdenhil, Ellen Kapiteijn, Marye J Boers-Sonderen, W Edward Fiets, Franchette W P J van den Berkmortel, Eva Ellebaek, Lisbet R Hölmich, Alexander C J van Akkooi, Winan J van Houdt, Michel W J M Wouters, Johannes V van Thienen, Christian U Blank, Aafke Meerveld-Eggink, Sebastian Klobuch, Sofie Wilgenhof, Ton N Schumacher, Marco Donia, Inge Marie Svane, John B A G Haanen

Research output: Contribution to journal › Article › Academic › peer-review

Fingerprint

Dive into the research topics of 'Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences